Analysis Result #1353

{
  "analysis": {
    "input_data": {
      "article": "Title: Q2 Results LIVE Updates: Markets shut but Sun Pharma, Britannia, Aurobindo report earnings today\n\nPublished: 2025-11-05\n\nContent: Q2 Results LIVE Updates: Multiple companies will be reporting their results for the September quarter on Wednesday, November 5, even as the stock exchanges are shut for trading on account of Guru Nanak Jayanti. Sun Pharma, Aurobindo Pharma, Piramal Pharma, Britannia Industries, Ramco Cements, Redington, Praj Industries, Delhivery, Inox India, Grasim Industries, Blue Star, BEML, Avanti Feeds, CSB Bank, CMS Info Systems, Allcargo Gati, are some of the companies reporting their earnings today. Watch this space for all the live updates.",
      "full_prompt_sent_to_llm": "=== NEWS ARTICLE ===\nTitle: Q2 Results LIVE Updates: Markets shut but Sun Pharma, Britannia, Aurobindo report earnings today\n\nPublished: 2025-11-05\n\nContent: Q2 Results LIVE Updates: Multiple companies will be reporting their results for the September quarter on Wednesday, November 5, even as the stock exchanges are shut for trading on account of Guru Nanak Jayanti. Sun Pharma, Aurobindo Pharma, Piramal Pharma, Britannia Industries, Ramco Cements, Redington, Praj Industries, Delhivery, Inox India, Grasim Industries, Blue Star, BEML, Avanti Feeds, CSB Bank, CMS Info Systems, Allcargo Gati, are some of the companies reporting their earnings today. Watch this space for all the live updates.\n\n=== TOP MATCHING STOCK FROM RAG ===\n\nSymbol: ALIVUS.NS\nCompany: Alivus Life Sciences Limited\nSector: Healthcare\nIndustry: Drug Manufacturers - Specialty \u0026 Generic\nSimilarity Score: 0.4292 (42.92%)\n\nMarket Data:\n\u2022 Current Price: 921.15\n\u2022 Previous Close: 924.4\n\u2022 Day Low: 915.15\n\u2022 Day High: 936.0\n\u2022 52-Week Low: 850.0\n\u2022 52-Week High: 1251.0\n\u2022 Volume: 611417\n\u2022 Avg Volume: 140400\n\nAdvanced Technical Indicators (21 total):\nClose_3d:920.60,924.40,921.15 | RSI:43.71 | MACD:-8.155/-7.426/-0.730 | BB:957.79/933.57/909.35 | MA:933.57/943.75 | ATR:25.97 | OBV:2,894,844 | WillR:-78.14 | CMF:-0.1201 | Ichi:931.90/989.23/960.56/989.23 | PSAR:938.43 | Aroon:12.00/32.00 | VWAP:1008.24 | Force:1188478.62 | Mass:25.37 | Coppock:-2.31 | UltOsc:39.35\n\nQuantitative Risk \u0026 Performance Metrics (35 total):\nAvgVol:126,491 | Price:921.15 | VaR:-0.0375/-0.0607 | CVaR:-0.0537/-0.0793 | Std:0.0259 | AnnVol:0.4108 | DownDev:0.0240 | Skew:0.3224 | Kurt:2.0832 | Sharpe:-0.0403 | MaxDD:-0.2847 | VolRat:2.7385 | P/MA20:0.9867 | P/MA50:0.9761 | VolReg:0.5585 | Mom:-0.0816/-0.0964 | MeanRet:-0.0000 | W/L:0.86 | Amihud:0.000000 | Roll:0.000000 | VolSurp:4.6427 | Omega:0.9993 | Sortino:-0.0041 | TailR:1.1138 | ESRat:1.4303 | Hurst:0.1973 | HalfL:11.01 | Mom120:-0.1493 | ApEn:0.7569\n\n=== ANALYZE THE ARTICLE (use RAG context if relevant) ===",
      "rag_context": {
        "company": "Alivus Life Sciences Limited",
        "country": "India",
        "description_preview": "[STOCK SYMBOL]: ALIVUS.NS\n[COMPANY NAME]: Alivus Life Sciences Limited\n[SECTOR]: Healthcare\n[INDUSTRY]: Drug Manufacturers - Specialty \u0026 Generic\n[COUNTRY]: India\n--------------------------------------...",
        "full_description": "[STOCK SYMBOL]: ALIVUS.NS\n[COMPANY NAME]: Alivus Life Sciences Limited\n[SECTOR]: Healthcare\n[INDUSTRY]: Drug Manufacturers - Specialty \u0026 Generic\n[COUNTRY]: India\n--------------------------------------------------------------------------------\ncountry - India\nindustry - Drug Manufacturers - Specialty \u0026 Generic\nsector - Healthcare\nlongBusinessSummary - Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives. The company also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. It exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.\nfullTimeEmployees - 2203\npreviousClose - 924.4\nopen - 936.0\ndayLow - 915.15\ndayHigh - 936.0\nregularMarketDayLow - 915.15\nregularMarketDayHigh - 936.0\ndividendRate - 5.0\ndividendYield - 0.54\nexDividendDate - 1756684800\npayoutRatio - 0.0\nbeta - 0.089\ntrailingPE - 22.85732\nvolume - 611417\nregularMarketVolume - 611417\naverageVolume - 140400\naverageVolume10days - 55057\naverageDailyVolume10Day - 55057\nmarketCap - 113185185792\nfiftyTwoWeekLow - 850.0\nfiftyTwoWeekHigh - 1251.0\npriceToSalesTrailing12Months - 4.715825\nfiftyDayAverage - 945.335\ntwoHundredDayAverage - 1026.0469\ntrailingAnnualDividendRate - 0.0\ntrailingAnnualDividendYield - 0.0\ncurrency - INR\nenterpriseValue - 108444811264\nforwardPE - 18.395407\nprofitMargins - 0.20652\nfloatShares - 30773741\nsharesOutstanding - 122681348\nheldPercentInsiders - 0.76132005\nheldPercentInstitutions - 0.07376\nbookValue - 229.77\npriceToBook - 4.009009\nearningsQuarterlyGrowth - 0.09\nnetIncomeToCommon - 4956789760\ntrailingEps - 40.3\nenterpriseToRevenue - 4.518\nenterpriseToEbitda - 15.578\nlastDividendValue - 5.0\nquoteType - EQUITY\ncurrentPrice - 921.15\ntargetHighPrice - 1382.0\ntargetLowPrice - 1150.0\ntargetMeanPrice - 1266.0\ntargetMedianPrice - 1266.0\nrecommendationKey - none\nnumberOfAnalystOpinions - 4\ntotalCash - 5488509952\ntotalCashPerShare - 44.753\nebitda - 6961392640\ntotalDebt - 566060032\ntotalRevenue - 24001140736\ndebtToEquity - 2.009\nrevenuePerShare - 195.811\ngrossProfits - 13366660096\nearningsGrowth - 0.088\nrevenueGrowth - 0.022\ngrossMargins - 0.55692\nebitdaMargins - 0.29004\noperatingMargins - 0.25795\nexchange - NSI\nlongName - Alivus Life Sciences Limited\nregularMarketPrice - 921.15\nepsTrailingTwelveMonths - 40.3\nepsCurrentYear - 42.13333\nshortName - ALIVUS LIFE SCIENCES LTD\ntrailingPegRatio - None\n--------------------------------------------------------------------------------\n[BUSINESS SUMMARY]\nAlivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives. The company also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. It exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.\n--------------------------------------------------------------------------------\n[IMPORTANT METRICS]\nCompany: Alivus Life Sciences Limited\nSector: Healthcare\nIndustry: Drug Manufacturers - Specialty \u0026 Generic\nCountry: India\nMarket Cap: 113.19B\nCurrent Price: 921.15\nP/E Ratio: 22.85732\nP/B Ratio: 4.009009\nDividend Yield: 0.5400%\nProfit Margin: 0.2065\nBeta: 0.0890\nVolume: 611,417\nAvg Volume: 140,400\nDay Range: 915.15 - 936.0\n52Wk Range: 850.0 - 1251.0\nTotal Revenue: 24001140736\nTotal Cash: 5.49B\nTotal Debt: 566.06M\nDebt to Equity: 2.009\nTarget Price: 1150.0 - 1382.0\nAnalyst Opinions: 4\nRecommendation: none\n--------------------------------------------------------------------------------\n[TECHNICAL] Close_3d:920.60,924.40,921.15 | RSI:43.71 | MACD:-8.155/-7.426/-0.730 | BB:957.79/933.57/909.35 | MA:933.57/943.75 | ATR:25.97 | OBV:2,894,844 | WillR:-78.14 | CMF:-0.1201 | Ichi:931.90/989.23/960.56/989.23 | PSAR:938.43 | Aroon:12.00/32.00 | VWAP:1008.24 | Force:1188478.62 | Mass:25.37 | Coppock:-2.31 | UltOsc:39.35\n--------------------------------------------------------------------------------\n[QUANT] AvgVol:126,491 | Price:921.15 | VaR:-0.0375/-0.0607 | CVaR:-0.0537/-0.0793 | Std:0.0259 | AnnVol:0.4108 | DownDev:0.0240 | Skew:0.3224 | Kurt:2.0832 | Sharpe:-0.0403 | MaxDD:-0.2847 | VolRat:2.7385 | P/MA20:0.9867 | P/MA50:0.9761 | VolReg:0.5585 | Mom:-0.0816/-0.0964 | MeanRet:-0.0000 | W/L:0.86 | Amihud:0.000000 | Roll:0.000000 | VolSurp:4.6427 | Omega:0.9993 | Sortino:-0.0041 | TailR:1.1138 | ESRat:1.4303 | Hurst:0.1973 | HalfL:11.01 | Mom120:-0.1493 | ApEn:0.7569",
        "industry": "Drug Manufacturers - Specialty \u0026 Generic",
        "sector": "Healthcare",
        "similarity_score": 0.429242164,
        "symbol": "ALIVUS.NS"
      }
    },
    "llm_analysis": {
      "actionable_summary": {
        "action": "watch",
        "bias": "neutral",
        "headline": "Q2 results flow during market holiday creates Thursday gap risk",
        "rationale": "Wait for Thursday open to trade earnings gaps"
      },
      "between_lines": "Market forced to wait but results will create gap moves Thursday",
      "confidence_score": 75,
      "connections": {
        "affects_directly": [
          "SUNPHARMA.NS",
          "AUROPHARMA.NS",
          "PIRAMAL.NS",
          "BRITANNIA.NS",
          "RAMCOCEM.NS",
          "REDINGTON.NS",
          "PRAJIND.NS",
          "DELHIVERY.NS",
          "INOXINDIA.NS",
          "GRASIM.NS",
          "BLUESTARCO.NS",
          "BEML.NS",
          "AVANTIFEED.NS",
          "CSBBANK.NS",
          "CMSINFO.NS",
          "ALLCARGO.NS"
        ],
        "affects_indirectly": [
          "NIFTY50",
          "NIFTYPHARMA",
          "NIFTYFMCG"
        ],
        "cause_effect_chain": "Results \u2192 Thursday gap moves \u2192 sector rebalancing",
        "follow_the_money": "Sector rotation post results"
      },
      "core": {
        "action": "earnings_beat/miss",
        "momentum": "neutral",
        "momentum_reasoning": "Markets shut so no immediate price reaction possible",
        "sector": "Healthcare",
        "topic": "Q2 earnings announcements",
        "trigger": "Multiple companies reporting Q2 results while markets closed"
      },
      "cross_stock_impact": [
        {
          "impact_strength": 0.4,
          "impact_type": "neutral",
          "reasoning": "Sun Pharma and Aurobindo results",
          "symbol": "NIFTYPHARMA"
        },
        {
          "impact_strength": 0.3,
          "impact_type": "neutral",
          "reasoning": "Britannia results",
          "symbol": "NIFTYFMCG"
        }
      ],
      "data_quality": {
        "article_length_tokens": 120,
        "has_financial_data": false,
        "has_price_data": false,
        "has_sentiment_indicators": true,
        "missing_critical_info": [
          "actual results data",
          "price reactions"
        ],
        "overall_quality_score": 0.5
      },
      "deals": {
        "counterparty": [],
        "deal_currency": null,
        "deal_size": null,
        "deal_type": null
      },
      "entities": [
        {
          "name": "Sun Pharma",
          "role": "catalyst",
          "ticker": "SUNPHARMA.NS",
          "type": "company"
        },
        {
          "name": "Aurobindo Pharma",
          "role": "catalyst",
          "ticker": "AUROPHARMA.NS",
          "type": "company"
        },
        {
          "name": "Britannia Industries",
          "role": "catalyst",
          "ticker": "BRITANNIA.NS",
          "type": "company"
        },
        {
          "name": "Piramal Pharma",
          "role": "catalyst",
          "ticker": "PIRAMAL.NS",
          "type": "company"
        },
        {
          "name": "Ramco Cements",
          "role": "catalyst",
          "ticker": "RAMCOCEM.NS",
          "type": "company"
        },
        {
          "name": "Redington",
          "role": "catalyst",
          "ticker": "REDINGTON.NS",
          "type": "company"
        },
        {
          "name": "Praj Industries",
          "role": "catalyst",
          "ticker": "PRAJIND.NS",
          "type": "company"
        },
        {
          "name": "Delhivery",
          "role": "catalyst",
          "ticker": "DELHIVERY.NS",
          "type": "company"
        },
        {
          "name": "Inox India",
          "role": "catalyst",
          "ticker": "INOXINDIA.NS",
          "type": "company"
        },
        {
          "name": "Grasim Industries",
          "role": "catalyst",
          "ticker": "GRASIM.NS",
          "type": "company"
        },
        {
          "name": "Blue Star",
          "role": "catalyst",
          "ticker": "BLUESTARCO.NS",
          "type": "company"
        },
        {
          "name": "BEML",
          "role": "catalyst",
          "ticker": "BEML.NS",
          "type": "company"
        },
        {
          "name": "Avanti Feeds",
          "role": "catalyst",
          "ticker": "AVANTIFEED.NS",
          "type": "company"
        },
        {
          "name": "CSB Bank",
          "role": "catalyst",
          "ticker": "CSBBANK.NS",
          "type": "company"
        },
        {
          "name": "CMS Info Systems",
          "role": "catalyst",
          "ticker": "CMSINFO.NS",
          "type": "company"
        },
        {
          "name": "Allcargo Gati",
          "role": "catalyst",
          "ticker": "ALLCARGO.NS",
          "type": "company"
        }
      ],
      "financials": {
        "buyback": null,
        "data_source": null,
        "dividend": null,
        "funding_amount": null,
        "guidance": null,
        "profit": null,
        "revenue": null,
        "valuation": null
      },
      "market_reaction": {
        "expected_impact": "Sector-specific moves Thursday",
        "index_impact": [
          "NIFTYPHARMA",
          "NIFTYFMCG"
        ],
        "price_change": null,
        "volume_change": null
      },
      "numerical_extractions": {
        "fiscal_period": "Q2 FY26",
        "mentioned_prices": [],
        "mentioned_targets": [],
        "poll_source": null,
        "profit_change_pct": null,
        "revenue_change_pct": null,
        "volume_growth_yoy_pct": null
      },
      "patterns": {
        "pattern_reasoning": "No trading session so pattern formation deferred",
        "pattern_type": null,
        "similar_past_event": null,
        "stage": "early",
        "strength": "weak"
      },
      "rag_alignment": {
        "rag_company_relevant": "no",
        "relevance_reasoning": "42.9 % similarity to Alivus Life Sciences which is not among the listed earnings reporters",
        "should_prioritize_rag": false,
        "similarity_interpretation": "weak_connection"
      },
      "reasoning_chain": [
        "Markets closed for Guru Nanak Jayanti",
        "18 companies reporting Q2 results",
        "No trading so no immediate reaction",
        "Thursday open will see gap moves based on results"
      ],
      "red_flags": [
        "No immediate price discovery due to holiday",
        "Results dispersion risk across sectors",
        "Overnight global events may override results"
      ],
      "sentiment": {
        "confidence": 0.8,
        "direction": "neutral",
        "drivers": [
          "no trading today",
          "earnings data pending market reaction",
          "broad sector coverage"
        ],
        "intensity": 0.3
      },
      "signals": {
        "crowd_behavior": {
          "source": "inference",
          "value": "confusion"
        },
        "key_levels": {
          "source": "inference",
          "values": []
        },
        "price_action_expected": {
          "source": "inference",
          "value": "volatile"
        },
        "reaction_reasoning": "Markets closed but results flow creates pent-up volatility for Thursday open",
        "volume_expectation": {
          "source": "inference",
          "value": "surge"
        }
      },
      "smart_money": {
        "big_players": [
          "domestic institutions",
          "retail"
        ],
        "evidence": "Market holiday prevents positioning",
        "retail_position": "neutral",
        "their_likely_motive": "Wait for Thursday opening to digest results"
      },
      "timing": {
        "catalyst_date": "2025-11-06",
        "expected_duration_days": 2,
        "temporal_anchor": "2025-11-05",
        "urgency": "today"
      },
      "trading_angles": [
        {
          "conviction": "medium",
          "idea": "Watch for earnings gaps on Thursday open",
          "reasoning": "Holiday creates information vacuum",
          "risk": "Overnight global moves"
        }
      ]
    },
    "metrics": {
      "model_params": {
        "max_completion_tokens": 8192,
        "model": "moonshotai/kimi-k2-instruct-0905",
        "reasoning_effort": "medium",
        "stream": false,
        "temperature": 0.4,
        "top_p": 0.9
      },
      "timing": {
        "end_time": "2025-11-05T03:51:38.619573",
        "llm_response_seconds": 4.369,
        "rag_query_seconds": 0.978,
        "start_time": "2025-11-05T03:51:33.271346",
        "total_duration_seconds": 5.348
      },
      "tokens": {
        "actual_from_api": {
          "input_tokens": 4735,
          "output_tokens": 1322,
          "total_tokens": 6057
        }
      }
    },
    "rag_match": {
      "company": "Alivus Life Sciences Limited",
      "sector": "Healthcare",
      "similarity_score": 0.429242164,
      "symbol": "ALIVUS.NS"
    },
    "timestamp": "2025-11-05T03:51:38.619642"
  },
  "article_id": "32138038-08da-4827-988e-02d79b317d04",
  "result_id": "20251105_035138",
  "status": "completed"
}